Lev Hayasmin Medical center, Natanya Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2015
NCT02483182
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Dermatology out-patients clinic, Lev Hayasmin - Medical center, Natanya, ISRAEL

Active Ingredients

Drugs in Phase 2 Trials (1)

aciclovir (zovirax) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Herpes Labialis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1